Invention Grant
- Patent Title: 4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors
-
Application No.: US16495802Application Date: 2018-03-22
-
Publication No.: US10793550B2Publication Date: 2020-10-06
- Inventor: Daniel Sutherlin , Steven McKerrall , Kwong Wah Lai
- Applicant: GENENTECH, INC.
- Applicant Address: US CA South San Francisco
- Assignee: GENENTECH, INC.
- Current Assignee: GENENTECH, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Viksnins Harris Padys Malen LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@250f698
- International Application: PCT/US2018/023740 WO 20180322
- International Announcement: WO2018/175707 WO 20180927
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D405/14 ; A61P9/00 ; A61P11/00 ; A61P19/02 ; A61P25/00 ; A61P25/02 ; A61P25/06 ; A61P25/24
Abstract:
The invention provides 4-piperidin-chroman-7-sulfonamide derivatives and salts thereof that are sodium channel modulators, as well as compositions containing such a compound or salt and therapeutic methods for using such a compound, salt, or composition.
Public/Granted literature
- US20200017469A1 4-PIPERIDIN-N-(PYRIMIDIN-4-YL)CHROMAN-7-SULFONAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS Public/Granted day:2020-01-16
Information query
